RxDoctor Payments Data

Shant Korkigian, DO

Otolaryngology · Novi, MINPI 1639402258

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (48.9%), speaking fees and education — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Alk-abello, Inc at 40.1% of the total. Reporting peaked in 2021 at $7,995 and has fallen 66.5% since, to $2,677 in 2025. Among otolaryngology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,957in general payments, 2019–2025

Across 297 payments — averaging $84.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alk-abello, Inc$10K
  • Intuitive Surgical$4K
  • Acclarent, Inc$3K
  • Integra Lifesciences Corporation$1K
  • GSK$1K
  • Medtronic$1K
  • plus $5K from 19 others

What the payments were for

  • Speaking & faculty fees$9,15037%
  • Travel & lodging$1,0744%
  • Food & beverage$12,19949%
  • Education$2,53410%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,957 in reported general payments places this provider in the 95th percentile of 257 otolaryngology providers in Michigan.

See all otolaryngology providers in Michigan

Medicare billing

Part B allowed, 2024
$122,736
Medicare patients
303
Services billed
1,085

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$48,365
Famotidine394$6,415
Ipratropium Bromide144$4,197
Cevimeline Hcl18$3,800
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth20$2,671
Pantoprazole Sodium169$2,661
Azelastine Hcl130$2,357
Betamethasone Dipropionate59$1,790
Omeprazole95$1,538
Fluconazole116$1,255
Fluticasone Propionate91$1,106
Nystatin29$1,002
Levocetirizine Dihydrochloride40$670
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$661
Diclofenac Sodium23$491

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Novi

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →